Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 54274-80-5 | MDL No. : | MFCD12965033 |
Formula : | C9H14O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LARSGJZNVQJRMD-UHFFFAOYSA-N |
M.W : | 170.21 | Pubchem ID : | 11252253 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.78 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 44.75 |
TPSA : | 43.37 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.8 cm/s |
Log Po/w (iLOGP) : | 1.92 |
Log Po/w (XLOGP3) : | 0.76 |
Log Po/w (WLOGP) : | 1.16 |
Log Po/w (MLOGP) : | 0.9 |
Log Po/w (SILICOS-IT) : | 1.54 |
Consensus Log Po/w : | 1.26 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.18 |
Solubility : | 11.3 mg/ml ; 0.0667 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.25 |
Solubility : | 9.56 mg/ml ; 0.0562 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.1 |
Solubility : | 13.4 mg/ml ; 0.0785 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.37 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | Stage #1: With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -65℃; for 0.5 h; Stage #2: With triethylamine In dichloromethane at -65℃; for 0.25 h; |
trans-4-Formyl-cyclohexanecarboxylic acid methyl ester To a solution of dimethylsulfoxide (9.53 g, 122 mmol) in dry dichloromethane (400 ml) was slowly added oxalyl chloride (7.74 g, 61.0 mmol) at -78° C. The cooling bath was removed and the reaction mixture was stirred at -50° C. for 5 min. A solution of trans-4-hydroxymethyl-cyclohexanecarboxylic acid methyl ester (8.75 g, 50.8 mmol) in dichloromethane (108 ml) was added at -65° C. Stirring for 30 minutes was followed by addition of triethylamine (25.7 g, 254 mmol). The cooling bath was removed 15 minutes after completed addition. The reaction mixture was quenched with 1 M aqueous hydrochloric acid solution (152 ml, 152 mmol) at -10° C. The layers were separated. The organic layer was washed with two 250 ml-portions of water and one 100-ml portion of brine, dried over anhydrous sodium sulfate and concentrated in vacuo to give the title compound as yellow oil (9.3 g, quantitative), which was used in the next step without further purification. MS m/e: 170 (M+) |
91% | Stage #1: With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -60℃; for 1.75 h; Stage #2: With triethylamine In dichloromethane at -60 - 0℃; for 1.5 h; |
(4) Under argon gas atmosphere to a solution of oxalyl chloride (4.48 mL) in methylene chloride (50 mL) was added dropwise a solution of dimethysulfoxide (4.55 g) in methylene chloride (5 mL) at -60 °C and the mixture was stirred at the same temperature for 15 minutes. To the mixture was added dropwise a solution of the compound obtained in the above step (3) (5.9 g) in methylene chloride (30 mL) over a period of 30 minutes and the mixture was stirred at the same temperature for 1 hour. To the reaction mixture was added dropwise triethylamine (16.7 mL) at -60 °C and the mixture was stirred at the same temperature for 30 minutes and then stirred at 0 °C for 1 hour. The reaction mixture was diluted with chloroform, washed successively with water, an aqueous 5 percent citric acid, water and brine, dried over sodium sulfate and concentrated in vacuo to give methyl trans-4-formylcyclohexanecarboxylate (5.32 g, yield: 91 percent) as an oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.4 mol | Stage #1: With hydrogenchloride In tetrahydrofuran; water at 0 - 5℃; for 4 h; Stage #2: With potassium hydroxide In methanol at 5 - 10℃; for 4 h; |
To 1L to three-opening bottle 0.42mol(I-B-c) and 210 ml tetrahydrofuran, three of the salt bath the solution in the bottle cooling to 0 °C; while maintaining the three port to the temperature of the solution in the bottle 0 °C -5 ° C under the condition of, instillment by in the bottle to the three port 50 ml concentrated hydrochloric acid and 50 ml of water, a mixed solution, after dripping maintaining the three port to the temperature of the solution in the bottle 0 °C -5 ° C stirring 4h; to the three-hole bottle is then added to 200 ml of methylene chloride and 200 ml water to liquid processing; finally, the liquid after treatment after the conventional treatment of the product, the formyl cyclohexyl carboxylic acid methyl ester (trans 75percent), the spare. 1L flask was added to the other three 200mL 0.21mol anhydrous methanol and potassium hydroxide, stirring hydroxidePotassium is dissolved, then cooling the solution bottle three to 5 ° C the temperature of the solution bottle holding three T<10 ° C Under the conditions, the three bottle before the dropwise addition of the standby formyl methyl cyclohexyl, aftercompletion of the dropwise addition, Holding three bottles solution temperature T <10 ° C was stirred for 4h After thereaction, the resulting reaction product was subjected to routine We were treated to give the transformylcyclohexylcarboxylate (IBd)0.4mol, yield 95.2percent, GC: 93.2percent. |
[ 94994-25-9 ]
Methyl 4-formylbicyclo[2.2.2]octane-1-carboxylate
Similarity: 0.96
[ 94994-15-7 ]
Methyl 4-(hydroxymethyl)bicyclo[2.2.2]octane-1-carboxylate
Similarity: 0.96
[ 18720-35-9 ]
4-(Methoxycarbonyl)bicyclo[2.2.2]octane-1-carboxylic acid
Similarity: 0.96
[ 711-01-3 ]
Methyl adamantane-1-carboxylate
Similarity: 0.96
[ 1459-96-7 ]
Dimethyl bicyclo[2.2.2]octane-1,4-dicarboxylate
Similarity: 0.96
[ 94994-25-9 ]
Methyl 4-formylbicyclo[2.2.2]octane-1-carboxylate
Similarity: 0.96
[ 20417-61-2 ]
Ethyl 2-formylcyclopropanecarboxylate
Similarity: 0.86
[ 13865-20-8 ]
Methyl 2,2-dimethyl-3-oxopropanoate
Similarity: 0.69
[ 50675-18-8 ]
Tetrahydropyran-4-carbaldehyde
Similarity: 0.68
[ 94994-25-9 ]
Methyl 4-formylbicyclo[2.2.2]octane-1-carboxylate
Similarity: 0.96
[ 94994-15-7 ]
Methyl 4-(hydroxymethyl)bicyclo[2.2.2]octane-1-carboxylate
Similarity: 0.96
[ 18720-35-9 ]
4-(Methoxycarbonyl)bicyclo[2.2.2]octane-1-carboxylic acid
Similarity: 0.96
[ 711-01-3 ]
Methyl adamantane-1-carboxylate
Similarity: 0.96
[ 1459-96-7 ]
Dimethyl bicyclo[2.2.2]octane-1,4-dicarboxylate
Similarity: 0.96